Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Breast Cancer”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Testing effectiveness (Phase 2)Study completedNCT01387295
What this trial is testing

Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease

Who this might be right for
Metastatic Breast CancerLiver Metastases
Dorte Nielsen 38
Very early researchLooking for participantsNCT07319195
What this trial is testing

Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)

Who this might be right for
Breast Cancer
Jennifer Zhang 32
Not applicableStudy completedNCT02685631
What this trial is testing

Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study

Who this might be right for
Localized Non-Resectable Adult Liver Carcinoma
Vanderbilt-Ingram Cancer Center 1,653
Early research (Phase 1)Study completedNCT01994369
What this trial is testing

Intraoperative Imagery of Breast Cancer With Folate-FITC (EC17)

Who this might be right for
Resectable Breast Cancer
University of Pennsylvania 10
Not applicableStudy completedNCT02833233
What this trial is testing

Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 5
Large-scale testing (Phase 3)Study completedNCT00314977
What this trial is testing

Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.

Who this might be right for
Breast Cancer
Radboud University Medical Center 200
Not applicableLooking for participantsNCT07218432
What this trial is testing

The TheraBionic P1 Device in Breast Cancer

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIA+2 more
Barbara Ann Karmanos Cancer Institute 24
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)Study completedNCT01099436
What this trial is testing

Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients

Who this might be right for
Breast Cancer
Borstkanker Onderzoek Groep 250
Early research (Phase 1)Temporarily pausedNCT04714983
What this trial is testing

DNX-2440 for Resectable Colorectal Liver Metastasis

Who this might be right for
Liver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more
DNAtrix, Inc. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03546686
What this trial is testing

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 51
Testing effectiveness (Phase 2)Study completedNCT00841828
What this trial is testing

Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 102
Early research (Phase 1)UnknownNCT03788083
What this trial is testing

Intratumoral TriMix Injections in Early Breast Cancer Patients

Who this might be right for
Breast Cancer FemaleEarly-stage Breast Cancer
Universitair Ziekenhuis Brussel 36
Testing effectiveness (Phase 2)Study completedNCT00633464
What this trial is testing

Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer

Who this might be right for
Triple Negative Locally Advanced Non-resectable Breast CancerMetastatic Breast Cancer
R-Pharm 79
Testing effectiveness (Phase 2)Study completedNCT00861705
What this trial is testing

Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Male Breast CarcinomaStage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7+2 more
National Cancer Institute (NCI) 454
Early research (Phase 1)Looking for participantsNCT06582017
What this trial is testing

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Who this might be right for
Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more
Nammi Therapeutics Inc 100
Testing effectiveness (Phase 2)Study completedNCT00951054
What this trial is testing

NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Nippon Kayaku Co., Ltd. 61
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00723125
What this trial is testing

Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer

Who this might be right for
Breast Cancer
William Sikov MD 60
Next Page